Ratings by WBB Securities (Steve Brozak)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/18/2021 Omeros Corp. OMER Maintain Strong Buy
(N/A)
 
 
  Details
5/28/2021 Redhill Biopharma RDHL Downgrade Buy
(Strong Buy)
7.14
(7.00)
-1.96% Details
4/23/2021 Paratek Pharmaceuticals PRTK Upgrade Buy
(Speculative Buy)
7.87
(7.23)
-8.13% Details
3/31/2021 ContraFect Corp. CFRX New Coverage Speculative Buy
(N/A)
4.48
(4.23)
-5.58% Details
1/8/2020 Paratek Pharmaceuticals PRTK New Coverage Speculative Buy
(N/A)
4.15
(7.23)
74.22% Details
7/12/2019 Redhill Biopharma RDHL Upgrade Strong Buy
(Buy)
6.59
(7.00)
6.22% Details
3/29/2019 Marker Therapeutics MRKR Upgrade Strong Buy
(Buy)
6.71
(3.20)
-52.31% Details
3/12/2019 Redhill Biopharma RDHL Upgrade Buy
(Speculative Buy)
8.27
(6.59)
-20.31% Details